| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers
|
Watanabe, Takahiro
|
|
2017
|
168 |
1 |
p. 135-145
|
artikel
|
| 2 |
Adding high-intensity interval training to conventional training modalities: optimizing health-related outcomes during chemotherapy for breast cancer: the OptiTrain randomized controlled trial
|
Mijwel, Sara
|
|
2017
|
168 |
1 |
p. 79-93
|
artikel
|
| 3 |
Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention
|
Dieli-Conwright, Christina M.
|
|
2017
|
168 |
1 |
p. 147-157
|
artikel
|
| 4 |
Are VNTRs co-localizing with breast cancer-associated SNPs?
|
Leclerc, Martin
|
|
2017
|
168 |
1 |
p. 277-281
|
artikel
|
| 5 |
Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study
|
Brouckaert, O.
|
|
2017
|
168 |
1 |
p. 189-196
|
artikel
|
| 6 |
Body mass index, diet, and exercise: testing possible linkages to breast cancer risk via DNA methylation
|
Gillman, Arielle S.
|
|
2017
|
168 |
1 |
p. 241-248
|
artikel
|
| 7 |
BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer
|
Nilsson, Martin P.
|
|
2017
|
168 |
1 |
p. 117-126
|
artikel
|
| 8 |
Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes
|
Volders, José H.
|
|
2017
|
168 |
1 |
p. 1-12
|
artikel
|
| 9 |
Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer
|
Rier, Hánah N.
|
|
2017
|
168 |
1 |
p. 95-105
|
artikel
|
| 10 |
Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials
|
Lynce, Filipa
|
|
2017
|
168 |
1 |
p. 35-41
|
artikel
|
| 11 |
Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening
|
Trentham-Dietz, Amy
|
|
2017
|
168 |
1 |
p. 229-239
|
artikel
|
| 12 |
Correction to: Breast-conserving surgery following neoadjuvant therapy-a systematic review on surgical outcomes
|
Volders, José H.
|
|
2018
|
168 |
1 |
p. 13-15
|
artikel
|
| 13 |
Discordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer
|
Dodson, Andrew
|
|
2017
|
168 |
1 |
p. 249-258
|
artikel
|
| 14 |
Does tacrolimus have any positive impact on outcome of post-transplant breast cancer patients?
|
Altundag, Kadri
|
|
2017
|
168 |
1 |
p. 283
|
artikel
|
| 15 |
Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES
|
Cheang, M. C. U.
|
|
2017
|
168 |
1 |
p. 169-178
|
artikel
|
| 16 |
Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer
|
Villegas, S. L.
|
|
2017
|
168 |
1 |
p. 179-187
|
artikel
|
| 17 |
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology
|
Mamounas, Eleftherios P.
|
|
2017
|
168 |
1 |
p. 69-77
|
artikel
|
| 18 |
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer
|
Pezo, Rossanna C.
|
|
2017
|
168 |
1 |
p. 159-168
|
artikel
|
| 19 |
Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer
|
Nyrop, K. A.
|
|
2017
|
168 |
1 |
p. 43-55
|
artikel
|
| 20 |
Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up
|
Asleh, Karama
|
|
2017
|
168 |
1 |
p. 107-115
|
artikel
|
| 21 |
Obesity’s impact on survival is independent of dose adjustments in neoadjuvant chemotherapy in women with breast cancer
|
Liu, Ying L.
|
|
2017
|
168 |
1 |
p. 285
|
artikel
|
| 22 |
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results
|
Press, David J.
|
|
2017
|
168 |
1 |
p. 207-220
|
artikel
|
| 23 |
Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
|
Bostner, Josefine
|
|
2017
|
168 |
1 |
p. 17-27
|
artikel
|
| 24 |
Real-world treatment in patients with HER2+ metastatic breast cancer
|
Colomer, R.
|
|
2017
|
168 |
1 |
p. 197-205
|
artikel
|
| 25 |
Relationship of histologic grade and histologic subtype with oncotype Dx recurrence score; retrospective review of 863 breast cancer oncotype Dx results
|
Singh, Kamaljeet
|
|
2017
|
168 |
1 |
p. 29-34
|
artikel
|
| 26 |
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial
|
O’Shaughnessy, Joyce
|
|
2017
|
168 |
1 |
p. 127-134
|
artikel
|
| 27 |
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer
|
Kwa, Maryann
|
|
2017
|
168 |
1 |
p. 57-67
|
artikel
|
| 28 |
Speed of processing training in middle-aged and older breast cancer survivors (SOAR): results of a randomized controlled pilot
|
Meneses, Karen
|
|
2017
|
168 |
1 |
p. 259-267
|
artikel
|
| 29 |
Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting
|
Abdel-Rahman, Omar
|
|
2017
|
168 |
1 |
p. 269-275
|
artikel
|
| 30 |
Willingness of breast cancer patients to undergo biopsy and breast cancer clinicians’ practices around seeking biopsy at the time of breast cancer relapse
|
Lohrisch, Caroline
|
|
2017
|
168 |
1 |
p. 221-228
|
artikel
|
Tijdschrift beschrijving